256 related articles for article (PubMed ID: 24900152)
21. Thyroid lesions incidentally detected by (18)F-FDG PET-CT - a two centre retrospective study.
Jamsek J; Zagar I; Gaberscek S; Grmek M
Radiol Oncol; 2015 Jun; 49(2):121-7. PubMed ID: 26029022
[TBL] [Abstract][Full Text] [Related]
22. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
Hagenimana N; Dallaire J; Vallée É; Belzile M
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
[TBL] [Abstract][Full Text] [Related]
23. [
Sollini M; Cozzi L; Pepe G; Antunovic L; Lania A; Di Tommaso L; Magnoni P; Erba PA; Kirienko M
Eur J Hybrid Imaging; 2017; 1(1):3. PubMed ID: 29782578
[TBL] [Abstract][Full Text] [Related]
24. The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions.
Sa R; Zhao HG; Dai YY; Guan F
Medicine (Baltimore); 2018 Sep; 97(38):e12521. PubMed ID: 30235771
[TBL] [Abstract][Full Text] [Related]
25. Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?
van Hoeij FB; Keijsers RG; Loffeld BC; Dun G; Stadhouders PH; Weusten BL
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):66-71. PubMed ID: 25139518
[TBL] [Abstract][Full Text] [Related]
26. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Jul; 23(5):427-35. PubMed ID: 19437097
[TBL] [Abstract][Full Text] [Related]
27. Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions.
Farghaly H; Alshareef M; Alqarni A; Sayed M; Nasr H
Eur J Radiol Open; 2020; 7():100268. PubMed ID: 32964074
[TBL] [Abstract][Full Text] [Related]
28. The relationship between HER2 expression and
Ozen A; Tatar G
Hell J Nucl Med; 2022; 25(1):5-10. PubMed ID: 35388798
[TBL] [Abstract][Full Text] [Related]
29. Significance of incidental focal fluorine-18 fluorodeoxyglucose uptake in colon/rectum, thyroid, and prostate: With a brief literature review.
Lee H; Hwang KH
World J Clin Cases; 2022 Dec; 10(34):12532-12542. PubMed ID: 36579086
[TBL] [Abstract][Full Text] [Related]
30. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.
Tian R; Su M; Tian Y; Li F; Li L; Kuang A; Zeng J
Skeletal Radiol; 2009 May; 38(5):451-8. PubMed ID: 19205695
[TBL] [Abstract][Full Text] [Related]
31. Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy.
Soffers F; Helsen N; Van den Wyngaert T; Carp L; Hoekstra OS; Goethals L; Martens M; Deben K; Spaepen K; De Bree R; De Geeter F; Zwezerijnen GJC; Van Laer C; Maes A; Lenssen O; Stroobants S;
EJNMMI Res; 2022 Jun; 12(1):34. PubMed ID: 35695940
[TBL] [Abstract][Full Text] [Related]
32. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.
Nakayama M; Okizaki A; Ishitoya S; Sakaguchi M; Sato J; Aburano T
Ann Nucl Med; 2013 Feb; 27(2):163-9. PubMed ID: 23188388
[TBL] [Abstract][Full Text] [Related]
33. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid
Shi H; Yuan Z; Yang C; Zhang J; Liu C; Sun J; Ye X
Clin Transl Oncol; 2019 Nov; 21(11):1561-1567. PubMed ID: 30924093
[TBL] [Abstract][Full Text] [Related]
34. Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan.
Chen YM; Huang G; Sun XG; Liu JJ; Chen T; Shi YP; Wan LR
Nucl Med Commun; 2008 May; 29(5):425-30. PubMed ID: 18391725
[TBL] [Abstract][Full Text] [Related]
35. Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.
Park T; Lee S; Park S; Lee E; Pahk K; Rhee S; Cho J; Kim C; Eo JS; Choe JG; Kim S
Nucl Med Mol Imaging; 2015 Mar; 49(1):42-51. PubMed ID: 25774237
[TBL] [Abstract][Full Text] [Related]
36. Assessment of incidental focal colorectal uptake by analysis of fluorine-18 fluorodeoxyglucose positron emission tomography parameters.
Lee H; Hwang KH; Kwon KA
World J Clin Cases; 2022 Jun; 10(17):5634-5645. PubMed ID: 35979099
[TBL] [Abstract][Full Text] [Related]
37. The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.
Hsiao YC; Wu PS; Chiu NT; Yao WJ; Lee BF; Peng SL
Clin Radiol; 2011 Dec; 66(12):1197-202. PubMed ID: 21907336
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.
Shi H; Yuan Z; Yuan Z; Yang C; Zhang J; Shou Y; Zhang W; Ping Z; Gao X; Liu S
Korean J Radiol; 2018; 19(2):342-351. PubMed ID: 29520193
[TBL] [Abstract][Full Text] [Related]
39. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.
Zhai G; Zhang M; Xu H; Zhu C; Li B
J Endocrinol Invest; 2010 Mar; 33(3):151-5. PubMed ID: 19783895
[TBL] [Abstract][Full Text] [Related]
40. The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.
Dunne RM; O'Mahony D; Wilson G; McDermott R; O'Keeffe SA
Br J Radiol; 2013 Jun; 86(1026):20130034. PubMed ID: 23568361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
